Theravance Biopharma, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2017 to 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Theravance Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2017 to 2024.
  • Theravance Biopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 48.8M shares, a 11.7% decline year-over-year.
  • Theravance Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 48.8M shares, a 11.7% decline from 2023.
  • Theravance Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 55.3M shares, a 24.9% decline from 2022.
  • Theravance Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 73.6M shares, a 5.95% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 48.8M -6.46M -11.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-07
2023 55.3M -18.3M -24.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-07
2022 73.6M +4.13M +5.95% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 69.5M +7.12M +11.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 62.3M +6.74M +12.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 55.6M +534K +0.97% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 55.1M +1.37M +2.56% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 53.7M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.